Skip to content

Comparison of platelet rich plasma and fractional Co2 laser on skin rejuvenation in patients with aging

Comparison of platelet rich plasma with fractional Co2 laser and fractional Co2 laser alone on skin rejuvenation in patients with aging

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201308281159N10
Enrollment
30
Registered
2013-09-22
Start date
2012-12-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Face wrinkles. Other specified disorders of skin and subcutaneous tissue

Interventions

Intervention 1: Treatment of platelet rich plasma (PRP) + fractional Co2 laser: First, patients will be anesthetized with topical Lidocaine-P and then will be treated with Co2 fractional laser (Dosis)
Treatment - Other
Treatment of platelet rich plasma (PRP) + fractional Co2 laser: First, patients will be anesthetized with topical Lidocaine-P and then will be treated with Co2 fractional laser (Dosis) with pixel pitc
Treatment with fractional Co2 laser alone: Patients will be anesthetized with topical Lidocaine-P and then will be treated with Co2 fractional laser (Dosis) with pixel pitch: 1, dot cycle: 3 and power

Sponsors

Vice chancellor for research, Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: Age 30-50 - Patients with mild to moderate wrinkles according to Glogue scale I-III – No coagulation disorders and use of anti coagulated drugs - No infection in treated site - No fever able diseases – No chronic liver diseases - No pregnancy or breast-feeding. Exclusion Criteria: Patients who will not return for follow up visits or are not willing to participate will be excluded.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Severity of face wrinkles. Timepoint: Before treatment and 1 and 3 months after treatment. Method of measurement: Glogue wrinkle scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactElaheh Haftbaradaran

Skin Diseases and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Ir

elahe_MD2003@YAHOO.COM+98 31 1337 3736

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026